Rain Oncology Inc (DELISTED) (RAIN:DL)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Jan 26, 16:00
Rain Oncology Shareholders Equity (Quarterly): 67.52M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 67.52M |
| June 30, 2023 | 73.29M |
| March 31, 2023 | 94.56M |
| December 31, 2022 | 113.04M |
| September 30, 2022 | 81.41M |
| June 30, 2022 | 98.28M |
| Date | Value |
|---|---|
| March 31, 2022 | 114.45M |
| December 31, 2021 | 130.50M |
| September 30, 2021 | 147.28M |
| June 30, 2021 | 164.83M |
| March 31, 2021 | -44.05M |
| December 31, 2020 | -37.42M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-44.05M
Minimum
Mar 2021
164.83M
Maximum
Jun 2021
83.64M
Average
96.42M
Median
Shareholders Equity (Quarterly) Benchmarks
| Icosavax Inc (DELISTED) | 232.38M |
| AbbVie Inc | 10.36B |
| Cerevel Therapeutics Holdings Inc | 673.74M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.06M |
| Total Liabilities (Quarterly) | 14.54M |